Background: This study evaluates the ability of MR/to stage transitional cell carcinoma of the upper urinary tract. Methods: Nine patients who had transitional cell carcinoma of the upper urinary tract detected by other imaging modalities underwent MR/examination at 1.5 T. Imaging included pre-and p
Pathological function of prostaglandin E2 receptors in transitional cell carcinoma of the upper urinary tract
โ Scribed by Yasuyoshi Miyata; Kojiro Ohba; Shigeru Kanda; Koichiro Nomata; Jiro Eguchi; Tomayoshi Hayashi; Hiroshi Kanetake
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 270 KB
- Volume
- 448
- Category
- Article
- ISSN
- 1432-2307
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND Contralateral, metachronous upper urinary tract (UUT) tumors after primary transitional cell carcinoma (TCC) of the UUT are reported rarely, and to the authors' knowledge the risk factors have not been determined to date. In addition, few reports have described the charac
The authors are indebted to Geron Corporation, Menlo Park, CA, for the gift of a human telomerase RNA component (hTR) probe; Dr.
Traditionally transitional cell tumors of the upper urinary tract are treated by nephroureterectomy. In circumstances where low functional renal reserve necessitates renal parenchymal preservation, endoscopic or percutaneous treatment may be an option for low grade and stage lesions. In this article